Navigation Links
Enzymes may point toward better therapies for prediabetes
Date:12/13/2012

AUGUSTA, Ga. Two enzymes that are elevated in prediabetes could hold clues to helping the 79 million Americans with the condition avoid serious vascular complications and maybe even identify those most at risk for full-blown diabetes, researchers say.

The enzymes, arginase and indoleamine 2,3 dioxygenase, or IDO, also have in common degrading amino acids, responding to inflammation and suppressing immunity, said Dr. William Caldwell, Chair of the Department of Pharmacology and Toxicology at the Medical College of Georgia at Georgia Health Sciences University.

That common ground has a newly formed research team watching how and why these two enzymes increase and how they may contribute to vascular problems in both an animal model of diabetes and a cohort of prediabetic humans.

They theorize a vicious cycle where elevated glucose increases production of inflammatory factors like cytokines and reactive oxygen species which in turn elevate arginase and IDO. The latter then further elevates cytokines and reactive oxygen species which damage blood vessels.

"You just put cells in high glucose and they start producing reactive oxygen species and these cytokines. It's a toxic situation," said Caldwell, cardiovascular pharmacologist and a principal investigator on the one-year, $450,000 seed grant from National Institute of Diabetes and Digestive and Kidney Diseases.

The animal model deficient in the satiety hormone leptin and at risk for vascular dysfunction enables the researchers to watch the scenario play out from normal to prediabetic to diabetes.

As they find, for example, cytokines in the animal model, they look in the blood of obese prediabetic people to see if they also find them there, said Dr. Yanbin Dong, MCG geneticist, cardiologist and principal investigator. They've already documented significantly increased levels of proinflammatory cytokines in prediabetic individuals, said Dr. Rudolf Lucas, MC
'/>"/>

Contact: Toni Baker
tbaker@georgiahealth.edu
706-721-4421
Georgia Health Sciences University
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Synchrotron gives insight into green energy enzymes
2. Enzymes implicated in disease processes attack one another instead of harming body proteins
3. Clemson researchers collect and reuse enzymes while maintaining bioactivity
4. Eagle Village Appoints Mike Mischley and Dani Montini to Board of Directors
5. Partnership Announcement between CoachingWebsites and Source Point Training to Offer Website Marketing and Online Business Solutions for Coaches.
6. Scripps Research Institute study points to potential new therapies for cancer and other diseases
7. Pathway identified in human lymphoma points way to new blood cancer treatments
8. Protein tug of war points toward better therapies for cardiovascular disease
9. Genetics point to serious pregnancy complication
10. ACP and WellPoint collaborate to give physicians the tools they need to participate in PCMH programs
11. Most Accurate Climate Models Point to More Global Warming
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Enzymes may point toward better therapies for prediabetes
(Date:7/31/2015)... , ... July 31, 2015 , ... ... industry players to know in predictive health analytics , Jvion continues to ... The firm creates predictive software that targets patient and population level illness to ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... important workshop at its new True North Conference Center. The medical community, social ... the Jacksonville community may be more aligned in the effort to better understand ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... According to the article published ... of the Pasadena courthouse was contained and extinguished by the city’s fire department before it ... the building at the time of the fire, and it was a fire alarm system ...
(Date:7/31/2015)... , ... July 31, 2015 , ... As part of ... community involvement and support of animal welfare organizations is essential to the longevity of ... consecutive year in the National Association of Professional Pet Sitters (NAPPS) annual Presents 4 ...
(Date:7/31/2015)... ... July 31, 2015 , ... Girl Scouts of Historic Georgia and ... through the Girl Scout "Be a Friend First" program. Representatives from Peach State Health ... , “Peach State Health Plan and our parent company, Centene Corporation, are dedicated to ...
Breaking Medicine News(10 mins):Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 4Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2
... researchers from King's College London has revealed that more than ... to die at home, but of them are unable to ... injection of funds, end of life programmes still lack proper ... Medical Journal. ,Lead researcher Professor Irene ...
... about the goodness of Vitamin E is about to receive ... Ohio State University who studied how two forms of vitamin ... the hypothesis. ,In the past couple of decades, benefits ... Most of it in the favour while some say that ...
... molecular map and other similar discoveries that could combat ... population//. ,'The inroads can give doctors the ... Soo Khee Chee, director of the National Cancer Centre ... included experts from the University of Hong Kong, University ...
... been known for a long time that mutual antagonism between ... disease//. It has now been possible to pinpoint the exact ... hardening of coronary arteries (atherosclerosis) in women while controlling behavior ... disease in men. ,Dr. Tim Smith and fellow ...
... study done to analyze the health benefits of anti-oxidants, ... a double-edged sword//. ,Everyday, a number of ... of consuming anti-oxidants. This study has warned that under ... lead to increased risk for development of cardiovascular disease, ...
... High Court would pass judgment regarding an appeal by health ... let a 17-month-old boy die//. Lawyers who are currently handling ... quality of life is so poor and that doctors should ... of the boy and the treating physicians have not been ...
Cached Medicine News:Health News:Vitamin E: good, bad or ugly??? 2Health News:Heart disease: Men Are From Mars, Women From Venus 2Health News:Vitamin E Can Lead To Heart Disease And Cancer 2Health News:Life Or Death: Parents Await High Court Judgment 2
(Date:7/30/2015)... International Inc. (NYSE: MTD ) today announced second ... , Sales in local currency increased 3% ... sales decreased 4% as currency reduced sales growth by ... diluted share as reported (EPS) were $2.73, compared with ... , an increase of 9% over the prior-year ...
(Date:7/30/2015)... , July 30, 2015  Tandem Diabetes ... device company and manufacturer of the t:slim® and ... entered into non-exclusive Development Agreements with Dexcom, Inc. ... insulin pumps with the Dexcom G5 and G6 ... Tandem,s next generation pump platform with Dexcom,s future ...
(Date:7/30/2015)... VANCOUVER , July 30, 2015  OncoGenex ... it will report its second quarter 2015 financial results ... a conference call and live webcast at 4:30 p.m. ... clinical development programs and a general corporate update. ... the Investor Relations page of the OncoGenex website at ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... from a pivotal trial suggests that ofatumumab has activity ... , , , ... Genmab A/S (OMX: GEN) announced today positive results from ... in the treatment of refractory chronic lymphocytic leukemia (CLL). ...
... HUNTINGTON BEACH, California and AMSTERDAM, December 8 ,Agendia, ... announced that,leading Agendia and the Netherlands Cancer Institute ... 2008 San Antonio Breast Cancer Symposium,(SABCS) and Agendia ... in Individualized Breast Cancer Therapy symposium. The San ...
Cached Medicine Technology:Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 2Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 3Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 4Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 5Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 6Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 8Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 9Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 2Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 3Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 4
Facilitates one-lung ventilation when using dual lumen endobronchial tubes....
... Double lumen tubes ... ventilation., ,Each ... is packaged with ... adaptors, suction catheters ...
Used for endobronchial blockade of the left or right lung for procedures which require one-lung ventilation. Supplied sterile in peel-open packages. Intended for one-time use....
The Pedia-Trake® is designed to reduce the possibility of over penetration., ,Pedia-Trake® is used to establish an emergency airway in pediatric patients more than one year old....
Medicine Products: